CHIARITO, MAURO
 Distribuzione geografica
Continente #
NA - Nord America 2.696
AS - Asia 2.520
EU - Europa 779
SA - Sud America 543
AF - Africa 79
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.624
Nazione #
US - Stati Uniti d'America 2.609
SG - Singapore 1.473
CN - Cina 466
BR - Brasile 452
VN - Vietnam 264
FI - Finlandia 151
IT - Italia 136
DE - Germania 114
IE - Irlanda 95
IN - India 71
FR - Francia 51
HK - Hong Kong 49
GB - Regno Unito 48
SE - Svezia 44
AR - Argentina 33
NG - Nigeria 32
MX - Messico 31
CA - Canada 30
NL - Olanda 29
TR - Turchia 27
IQ - Iraq 24
BD - Bangladesh 22
ID - Indonesia 17
PL - Polonia 15
RU - Federazione Russa 15
JP - Giappone 12
PY - Paraguay 12
UA - Ucraina 12
ES - Italia 11
MA - Marocco 11
CL - Cile 10
SA - Arabia Saudita 10
VE - Venezuela 9
AZ - Azerbaigian 8
CO - Colombia 8
KE - Kenya 8
ZA - Sudafrica 8
PE - Perù 7
PK - Pakistan 7
TH - Thailandia 7
BE - Belgio 6
EC - Ecuador 6
RO - Romania 6
TW - Taiwan 6
AT - Austria 5
BO - Bolivia 5
DZ - Algeria 5
JO - Giordania 5
KZ - Kazakistan 5
LT - Lituania 5
AU - Australia 4
BA - Bosnia-Erzegovina 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
EG - Egitto 4
IL - Israele 4
JM - Giamaica 4
KG - Kirghizistan 4
MY - Malesia 4
OM - Oman 4
PH - Filippine 4
TN - Tunisia 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
BY - Bielorussia 3
CR - Costa Rica 3
CU - Cuba 3
HN - Honduras 3
HU - Ungheria 3
IR - Iran 3
NO - Norvegia 3
NP - Nepal 3
PA - Panama 3
PT - Portogallo 3
RS - Serbia 3
AL - Albania 2
CH - Svizzera 2
CY - Cipro 2
HR - Croazia 2
LB - Libano 2
LV - Lettonia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
CW - ???statistics.table.value.countryCode.CW??? 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
Totale 6.614
Città #
Singapore 640
Ashburn 347
San Jose 301
The Dalles 245
Shanghai 226
Chandler 193
Dallas 152
Helsinki 150
Beijing 112
Boardman 112
New York 107
Wilmington 106
Dublin 94
Ho Chi Minh City 84
Los Angeles 64
Hanoi 56
San Mateo 50
Milan 48
São Paulo 42
Hong Kong 41
Pune 38
Benin City 32
Munich 26
Lawrence 22
Princeton 22
Falkenstein 21
Ann Arbor 20
Amsterdam 19
Seattle 17
Leawood 16
Orem 15
Warsaw 14
Brasília 13
Council Bluffs 13
Da Nang 13
Fairfield 13
Santa Clara 13
Woodbridge 13
Brooklyn 12
Haiphong 12
Chicago 11
Curitiba 11
Frankfurt am Main 11
Montreal 10
Paris 10
Rio de Janeiro 10
Stockholm 10
Hillsboro 9
Assago 8
Cologno Monzese 8
Phoenix 8
Turin 8
Baghdad 7
Chennai 7
Goiânia 7
Johannesburg 7
Kocaeli 7
Manchester 7
Mexico City 7
Naples 7
Tokyo 7
Toronto 7
Asunción 6
Baku 6
Biên Hòa 6
Boston 6
Brussels 6
Can Tho 6
Denver 6
Hải Dương 6
Lima 6
London 6
Moscow 6
Thái Nguyên 6
Abbiategrasso 5
Ankara 5
Campinas 5
Istanbul 5
Juiz de Fora 5
Nairobi 5
Norwalk 5
Porto Alegre 5
Redmond 5
San Francisco 5
Santo André 5
Taipei 5
Belo Horizonte 4
Brescia 4
Fortaleza 4
Ha Long 4
Jeddah 4
Kuala Lumpur 4
Muscat 4
New Delhi 4
Osasco 4
Reston 4
Salvador 4
Tashkent 4
Amman 3
Bangkok 3
Totale 3.904
Nome #
Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis. 121
Direct oral anticoagulants in addition to antiplatelet therapy for secondary prevention after acute coronary syndromes: an updated systematic review and meta-analysis 120
Coral Reef Aorta: A Rare Occlusive Disease of the Aorta Complicating Decision Making for Severe Aortic Stenosis Treatment. 108
Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: Effects on blood pressure control and mortality 107
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19 99
Acute coronary syndrome in a patient with a residual aortic dissection flap after supracoronary aortic replacement: the role of intravascular ultrasound 98
Cardioprotection with nebivolol in patients undergoing anthracyclines: a randomized placebo-controlled trial 93
Coronary Revascularisation in Transcatheter Aortic Valve Implantation Candidates: Why, Who, When? Interv Cardiol. 87
Clinical outcomes with reservoir-based polymer-free amphilimus-eluting stents in real-world patients according to diabetes mellitus and complexity: The INVESTIG8 registry. 86
Impact of Diabetes on Clinical Outcomes After Polymer-Free Amphilimus- and Biolimus-Eluting Stent Implantation 85
Antiplatelet therapy for secondary prevention of cardiovascular disease: challenging the certainties 82
Coronary Artery Dissection in Drug-Coated Balloon Angioplasty: Incidence, Predictors, and Clinical Outcomes 82
The synergy stent in high-bleeding risk patients: why design matters 81
Balloon Versus Self-Expandable Valve for the Treatment of Bicuspid Aortic Valve Stenosis: Insights from the BEAT International Collaborative Registrys 81
Characterization of Myocardial Injury in Patients With COVID-19 78
Is Transcatheter Aortic Valve Replacement Superior to Surgical Aortic Valve Replacement? A Meta-Analysis of Randomized Controlled Trials. 77
Clinical challenges in an unusual setting: ST-elevation in a patient suffering from graft versus host disease, between thrombosis and coronary spasm 77
Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials 76
Predicting survival in patients with severe heart failure: risk scores validation in the HELP-HF cohort 75
Prognostic role of mitral regurgitation in patients with advanced heart failure 74
Left atrial appendage closure with the Ultraseal device: Initial experience and mid-term follow-up. 73
P2Y12 vs. aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and Meta-analysis 70
A Complicated Case of Resistant Hypertension 70
Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry 69
Impact of High-Density Lipoprotein Levels on Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents 68
Cardiac and sudden death after chronic total occlusion percutaneous coronary intervention: Prognostic role of the target vessel 67
A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry 67
Direct oral anticoagulants versus Vitamin K antagonists in the treatment of left ventricular thrombosis: a systematic review and meta-analysis 67
Safety and efficacy of polymer-free biolimus-eluting stents in all-comer patients: the RUDI-FREE study. 67
[Two-step strategy for the treatment of complex coronary artery disease and aortic stenosis in a patient with severely impaired left ventricular function] 64
Coronary Revascularisation in Transcatheter Aortic Valve Implantation Candidates: Why, Who, When? 64
Safety and efficacy of polymer-free drug-eluting stents: Amphilimus-eluting Cre8 versus biolimus-eluting biofreedom stents 64
Lower dose direct oral anticoagulants and improved survival: A combined analysis in patients with established atherosclerosis 63
Mitral Valve Stenosis after Transcatheter Aortic Valve Replacement: Case Report and Review of the Literature 61
The Placebo Effect on Symptoms, Quality of Life, and Functional Outcomes in Patients With Angina Pectoris: A Meta-analysis of Randomized Placebo-Controlled Trials 60
Impact of Race/Ethnicity on Long Term Outcomes After Percutaneous Coronary Intervention with Drug-Eluting Stents 58
Long-term prognostic impact of subclinical myocardial dysfunction in patients recovered from COVID-19 58
Outcome after percutaneous edge-to-edge mitral repair for functional and degenerative mitral regurgitation: a systematic review and meta-analysis 57
GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis 57
Impact of complete revascularization on mortality in patients with ST-segment elevation myocardial infarction and multivessel disease: an updated meta-analysis 57
Radial versus femoral access for coronary interventions: An updated systematic review and meta-analysis of randomized trials 56
Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey 56
Transcatheter Self-Expandable Valve Implantation for Aortic Stenosis in Small Aortic Annuli The TAVI-SMALL Registry 56
Impact of anemia on short-term outcomes after TAVR: A subgroup analysis from the BRAVO-3 randomized trial 56
A sex paradox in clinical outcomes following complex percutaneous coronary intervention 55
Application of the Academic Research Consortium High Bleeding Risk criteria in patients treated with coronary bioresorbable polymer everolimus-eluting stents: Insights from the POEM trial 54
Prognostic Value of Baseline Inflammation in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary Intervention 53
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in all-comers population. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 53
Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysis 53
Long COVID-19 Cardiac Complications Are Associated With Autoimmunity to Cardiac Self-Antigens Sufficient to Cause Cardiac Dysfunction 53
One-year clinical outcome of amphilimus polymer-free drug-eluting stent in diabetes mellitus patients: Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTre rEgistry) 52
Edge-to-edge percutaneous mitral repair for functional ischaemic and non-ischaemic mitral regurgitation: a systematic review and meta-analysis 52
Nebivolol versus placebo in patients undergoing anthracyclines (CONTROL Trial): rationale and study design 52
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients presenting with acute myocardial infarction: Insight from the ULISSE registry 51
Safety and efficacy of an ultra low dose fluoroscopic protocol for chronic total occlusion recanalization 51
Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench-to-bedside 51
Impact of target vessel choice on outcomes following percutaneous coronary intervention in patients with a prior coronary artery bypass graft 50
Midterm and one-year outcome of amphilimus polymer free drug eluting stent in patients needing short dual antiplatelet therapy. Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTer rEgistry) 50
Impact of Small Valve Size on 1-Year Outcomes After Transcatheter Aortic Valve Implantation in Women (from the WIN-TAVI Registry) 49
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in diabetic patients: Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 49
Predictors and Clinical Impact of Prosthesis-Patient Mismatch After Self-Expandable TAVR in Small Annuli 47
Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry 47
Low-Dose Colchicine after Myocardial Infarction 47
Drug-eluting stents in diabetic patients: Are we still treading water? 46
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry 46
Prognostic value of tricuspid regurgitation 46
Periprocedural outcome in patients undergoing left atrial appendage occlusion with the Watchman FLX device: The ITALIAN-FLX registry 45
Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleeding 45
Panta rhei, also drug eluting stent technology 44
Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI registry 44
Treating Inflammation Prior to Percutaneous Coronary Intervention: Does the Heart Care? 44
Perioperative risk and antiplatelet management in patients undergoing non-cardiac surgery within 1 year of PCI 44
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study 43
The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent 43
Risk of cardiac and sudden death with and without revascularisation of a coronary chronic total occlusion 43
Prevalence and Impact of High Bleeding Risk in Patients Undergoing Left Main Artery Disease PCI 43
Evolving Devices and Material in Transcatheter Aortic Valve Replacement: What to Use and for Whom 43
Artificial Intelligence and Cardiovascular Risk Prediction: All That Glitters is not Gold 43
Types of myocardial injury and mid-term outcomes in patients with COVID-19 42
Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI: A Prespecified TWILIGHT Substudy 42
Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: A systematic review and meta-analysis 42
Transcatheter aortic valve replacement in patients with end-stage renal disease: Is "better than nothing" good enough? 41
Efficacy and Safety of P2Y12 Inhibitor Monotherapy After Complex PCI: A Collaborative Systematic Review and Meta-Analysis 41
Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic review and meta-analysis 41
Young Patient with Advanced Heart Failure No Longer a Candidate for Heart Transplantation after MitraClip® Procedure 41
Single or dual antiplatelet therapy after transcatheter aortic valve implantation. A meta-analysis of randomized controlled trials 41
The Cre8 amphilimus-eluting stent for the treatment of coronary artery disease: safety and efficacy profile 41
Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure 41
Clinical and prognostic implications of heart failure hospitalization in patients with advanced heart failure 40
Polymer-free amphilimus-eluting stent versus biodegradable polymer biolimus-eluting stent in patients with and without diabetes mellitus 40
Vitamin D and Cardiovascular Diseases: From Physiology to Pathophysiology and Outcomes 40
PROGNOSTIC VALUE OF HIGH-SENSITIVITY C-REATIVE PROTEIN AMONG CHRONIC KIDNEY DISEASE PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION 40
Postoperative Delirium in Individuals Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis 39
Clinical burden and predictors of non-cardiovascular mortality and morbidity in advanced heart failure 39
Prognostic value of hypochloremia on mortality in patients with heart failure: a systematic review and meta-analysis 39
Two-year cardiac mortality after MitraClip treatment of functional mitral regurgitation in ischemic and non-ischemic dilated cardiomyopathy 38
SGLT2 inhibitors: a therapy for everybody but not for anything? 38
P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events 37
Perioperative Management of P2Y12 Inhibitors in Patients Undergoing Cardiac Surgery within 1 Year of PCI 37
Percutaneous mitral valve repair in acute mitral regurgitation: case report and review of the literature 37
Totale 5.800
Categoria #
all - tutte 41.636
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.636


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202157 0 0 0 0 0 0 0 0 0 31 0 26
2021/2022137 5 2 5 28 3 1 4 23 11 8 34 13
2022/2023756 54 18 32 96 75 48 16 45 151 106 85 30
2023/2024917 89 84 169 76 34 110 56 58 20 51 78 92
2024/20251.388 32 5 29 23 23 165 84 105 224 346 183 169
2025/20263.302 516 291 213 331 153 202 1.053 194 172 177 0 0
Totale 6.712